SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nymox Pharmaceuticals (nymx) -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (12)3/1/2001 1:04:29 PM
From: Kenneth V. McNutt  Read Replies (1) | Respond to of 16
 
<<Nymox is currently marketing its AlzheimAlert(TM) test in the United States
through a medical marketing force of 50 medical representatives.
AlzheimAlert(TM) costs $295.>>

Thanks for the heads up, Gary. I had lost track of the Nymx. I see it is up 0.44 this early pm.
Will look into it more closely. At least at $2+ it can't drop too far. Not like my other winners.g
Ken


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News